SA

Surekha Avinash Pophali

Active Director Director DIN 03308388
DIN 03308388 First appointment May 2011 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2011
Shareholding value •••• Premium profile

About Surekha Avinash Pophali

Data last updated:

Surekha Avinash Pophali is a Director at Central India Institute Of Haematology And Oncology Private Limited (since 2011). The company operates in Healthcare. Central India Institute Of Haematology And Oncology Private Limited reported revenue of ₹3.79 Cr (FY 2025).

DIN 03308388
Primary Designation Director
Industry Healthcare
First Appointment 12 May 2011
Oldest Company Age 15 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 May 20112011₹3.79 Cr (FY 2025)Active

Board colleagues of Surekha Avinash Pophali

Directorship timeline

Open interactive timeline →
Central India Institute Of Haematology And Oncology Private Limited
Premium access

Shareholding and investment profile for Surekha Avinash Pophali

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surekha Avinash Pophali

Surekha Avinash Pophali currently holds 1 directorship: Central India Institute Of Haematology And Oncology Private Limited (Director, since 12 May 2011, revenue ₹3.79 Cr (FY 2025)).

Surekha Avinash Pophali was first appointed on 12 May 2011 as Director at Central India Institute Of Haematology And Oncology Private Limited.

The current boards of Surekha Avinash Pophali's companies include Avinash Keshaorao Pophali (Central India Institute Of Haematology And Oncology Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available